Today: RBC Capital Markets Downgrade CRH Medical Corp (CRHM) to Sector Perform

Today: RBC Capital Markets Downgrade CRH Medical Corp (CRHM) to Sector Perform

CRH Medical Corp (NASDAQ:CRHM) was downgraded by equities researchers at RBC Capital Markets from an “outperform” rating to a “sector perform” rating in a report issued on Monday, The Fly reports.

A number of other brokerages also recently weighed in on CRHM. Zacks Investment Research downgraded shares of CRH Medical Corp from a “buy” rating to a “hold” rating in a report on Monday, September 5th. Canaccord Genuity set a $6.00 target price on shares of CRH Medical Corp and gave the stock a “buy” rating in a report on Thursday, October 27th. Finally, CIBC restated an “outperform” rating on shares of CRH Medical Corp in a report on Tuesday, September 13th.

CRH Medical Corp (NASDAQ:CRHM) traded down 9.68% during trading on Monday, hitting $5.60. 278,167 shares of the stock were exchanged. The firm has a 50-day moving average of $4.98 and a 200-day moving average of $3.98. CRH Medical Corp has a 52 week low of $2.15 and a 52 week high of $6.30.

Several institutional investors have recently added to or reduced their stakes in CRHM. TFS Capital LLC bought a new position in CRH Medical Corp during the second quarter valued at approximately $138,000. Counsel Portfolio Services Inc. bought a new position in CRH Medical Corp during the second quarter valued at approximately $485,000. Morgan Stanley increased its position in CRH Medical Corp by 335.9% in the third quarter. Morgan Stanley now owns 157,800 shares of the company’s stock valued at $601,000 after buying an additional 121,600 shares in the last quarter. Palladium Partners LLC increased its position in CRH Medical Corp by 109.5% in the third quarter. Palladium Partners LLC now owns 221,900 shares of the company’s stock valued at $845,000 after buying an additional 116,000 shares in the last quarter. Finally, Ativo Capital Management LLC bought a new position in CRH Medical Corp during the second quarter valued at approximately $1,076,000.

CRH Medical Corp Company Profile

CRH Medical Corporation, formerly Medsurge Medical Products Corp., is a healthcare products and services company. The Company operates through segments, including the sale of medical products and the provision of anesthesia services. The Company specializes in the treatment of hemorrhoids utilizing its treatment protocol and technology.

Related posts

Leave a Comment